Gerresheimer AG (ETR:GXI)

Market Cap	976.79M -34.9%
Revenue (ttm)	2.32B +16.6%
Net Income	-320.32M
EPS	-9.27
Shares Out	34.54M
PE Ratio	n/a
Forward PE	12.82
Dividend	n/a
Ex-Dividend Date	n/a

Volume	217,087
Open	28.30
Previous Close	28.28
Day's Range	27.90 - 29.96
52-Week Range	14.83 - 44.76
Beta	0.48
Analysts	Hold
Price Target	27.38 (-8.24%)
Earnings Date	Aug 27, 2026

About Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, provides drug containment solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization, and contract manufacturing of drug delivery programs; project and quality manag...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1864
• Employees: 13,528
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: GXI

Analyst Summary

According to 13 analysts, the average rating for GXI stock is "Hold." The 12-month stock price target is €27.38, which is a decrease of -8.24% from the latest price.

Price Target

€27.38

(-8.24% downside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 7, 2026

Data Sources Report a data error